ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103040 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
+6.8%
Revenue CAGR (3yr)
4.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $21M | $23M | $24M | +5.3% | +6.8% |
| Operating Expenses | $20M | $22M | $23M | +6.2% | +6.6% |
| Operating Margin | 4.3% | 5.5% | 4.6% | -15.0% | +4.1% |
| Net Income | $1M | $1M | $1M | -10.4% | +11.1% |
| Licensed Beds | 75 | 75 | 75 | +0.0% | +0.0% |
| Total Patient Days | 16,077 | 16,349 | 16,106 | -1.5% | +0.1% |
| Medicare Day % | 70% | 72% | 65% | -10.4% | -4.1% |
| Medicaid Day % | 1% | 0% | 1% | +82.3% | +6.1% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.0% ($21M → $24M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.8%
This Hospital
+7.6%
State Avg
Latest Margin
4.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $26M | 4.8% |
| FY2024 (proj) | $27M | 5.0% |
| FY2025 (proj) | $29M | 5.2% |